Share

cover art for How Real-World Evidence can help tackle the global burden of diabetes and chronic kidney disease

D-Talk

How Real-World Evidence can help tackle the global burden of diabetes and chronic kidney disease

Season 1, Ep. 13

Data from the IDF Diabetes Atlas Report on diabetes and kidney disease released in 2023, indicate that approximately 30 to 40% of people living with diabetes develop CKD. Furthermore, over the last 20 years, CKD due to type 2 diabetes has increased worldwide by about 74%. In this episode of D-Talk, host Phyllisa Deroze welcomes Professors Mustafa Arici and Ruben Silva Tinoco to explore how the iCaReMe registry can bridge gaps in early diagnosis and prevent diabetes-related kidney complications.

 

More episodes

View all episodes

  • 12. Basic and Translational Science

    30:12||Season 1, Ep. 12
    Join host Phyllisa Deroze as she delves into the world of basic and translational science — two powerful forces reshaping the landscape of diabetes management and care — with Prof Michael Roden, a leading expert in the field and lead of the Basic and Translational Science stream at the IDF World Diabetes Congress in Bangkok. From "lab to life," discover how research is expanding our understanding of diabetes subtypes and energy metabolism while paving the way for personalised treatments.
  • 11. Diabetic Retinopathy: a call for global action

    42:44||Season 1, Ep. 11
    In this episode of D-Talk, Dr. Covadonga Bascaran and Professor Sehnaz Karadeniz join host Phyllisa Deroze to discuss a common diabetes-related complication: diabetic retinopathy (DR). DR can develop in anyone living with type 1 or type 2 diabetes and other types of diabetes, such as LADA. In 2020, an estimated 103 million adults had diabetic retinopathy (DR), and over 47 million had vision-threatening retinopathy requiring prompt treatment to preserve vision.
  • 10. Diabetes and chronic kidney disease

    32:35||Season 1, Ep. 10
    In this episode of D-Talk, Professors Antonio Ceriello and Roberto Pecoits-Filho join host Phyllisa Deroze to explore the prevalence of diabetes and chronic kidney disease (CKD). Numbers show that over 530 million people live with diabetes, and over 850 million are affected by CKD, with an increase in both conditions in recent decades. In this podcast, guests and hosts examine the links between diabetes and CKD and the benefits of a multisectoral approach to prevent and treat both conditions and improve the lives of people affected or at risk.
  • 9. Diabetes among Indigenous Peoples

    27:43||Season 1, Ep. 9
    In this episode of D-Talk, Phyllisa Deroze is joined by Courtney Fischer-Claussen and Dr. Emily Papadimos to highlight the prevalence and impact of type 2 diabetes among Indigenous Peoples across all age groups. There are approximately 476 million Indigenous Peoples living in 90 countries, comprising over 6% of the world's population.
  • 8. Understanding the impact of diabetes-related foot complications

    31:00||Season 1, Ep. 8
    In this episode of D-Talk, Phyllisa Deroze is joined by Dr Matilde Monteiro-Soares and Dr Hermelinda Pedrosa to examine the impact of diabetes-related foot complications, one of the most common and serious complications affecting people with diabetes across the world. With the increasing prevalence of diabetes, the chances of experiencing foot-related complications are also on the rise. These complications can vary from minor problems like calluses and corns to more severe conditions like ulcers and infections, which may require lower limb amputation. The impact of these complications on a patient's quality of life is significant, highlighting the importance of understanding their causes, risks and preventive measures. So, what can be done to reduce the risk and impact of diabetes-related foot complications? And how can registries help? 
  • 7. Type 1 diabetes: a condition that impacts all ages

    24:40||Season 1, Ep. 7
    In this episode of D-Talk, Phyllisa Deroze is joined by Professor Dianna Magliano and Professor Graham Ogle to put the spotlight on type 1 diabetes. Together they delve into the prevalence of type 1 diabetes and its growing impact across the globe. Type 1 diabetes is a condition that almost 9 million of us live with worldwide. Although it has traditionally been thought of as a condition that primarily affects children, new figures show that three in five new cases in 2022 were in people aged 20 and older. So, what's the story behind the statistics, and what do we really know about the evolution of type 1 diabetes across the globe?  
  • 6. Obesity and type 2 diabetes: a joint approach to halt the rise

    51:26||Season 1, Ep. 6
    IDF welcomes Professors Louise Baur and Mike Lean to discuss the links between obesity and type 2 diabetes and the actions required to reduce the growing impact of the two conditions across the world.Any opinions expressed during this podcast are those of the speakers, and do not necessarily represent the views of IDF.Podcast hosted by Phyllisa Deroze
  • 5. Diabetes and Covid-19

    26:32||Season 1, Ep. 5
    Phyllisa Deroze welcomes Dr Gillian Booth and Dr Luke Wander for a discussion on what we know about the connections between Covid-19 and diabetes and how the pandemic has impacted the lives of people living with diabetes.